Detalles de la búsqueda
1.
Elaboration of Consensus Clinical Endpoints to Evaluate Antimicrobial Treatment Efficacy in Future Hospital-acquired/Ventilator-associated Bacterial Pneumonia Clinical Trials.
Clin Infect Dis
; 69(11): 1912-1918, 2019 11 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-30722013
2.
Efficacy and Safety of Tedizolid Phosphate versus Linezolid in a Randomized Phase 3 Trial in Patients with Acute Bacterial Skin and Skin Structure Infection.
Antimicrob Agents Chemother
; 63(7)2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30988146
3.
Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study.
Eur Respir J
; 41(5): 1107-15, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23018904
4.
Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results.
Eur Respir J
; 40(1): 17-27, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22135277
5.
New Antimicrobial Agentsââ ââbut No Susceptibility Tests!
Clin Infect Dis
; 63(11): 1530-1531, 2016 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27581762
6.
A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infections.
J Antimicrob Chemother
; 66(11): 2632-42, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21896561
7.
Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial.
Lancet Infect Dis
; 20(3): 330-340, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31866328
8.
Effects of prior effective therapy on the efficacy of daptomycin and ceftriaxone for the treatment of community-acquired pneumonia.
Clin Infect Dis
; 46(8): 1142-51, 2008 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18444848
9.
Evaluation of endocarditis caused by methicillin-susceptible Staphylococcus aureus developing nonsusceptibility to daptomycin.
J Clin Microbiol
; 46(1): 220-4, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18003803
10.
Associations between the genotypes of Staphylococcus aureus bloodstream isolates and clinical characteristics and outcomes of bacteremic patients.
J Clin Microbiol
; 46(9): 2890-6, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18596141
11.
In vitro activity of daptomycin against multidrug-resistant Staphylococcus aureus and S. aureus with known virulence factors, including community-acquired methicillin-resistant isolates.
Diagn Microbiol Infect Dis
; 61(3): 339-42, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18304772
12.
In Vitro activities of Tedizolid and comparator antimicrobial agents against clinical isolates of Staphylococcus aureus collected in 12 countries from 2014 to 2016.
Diagn Microbiol Infect Dis
; 89(2): 151-157, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28793964
13.
In vitro activity of daptomycin against clinical isolates with reduced susceptibilities to linezolid and quinupristin/dalfopristin.
Int J Antimicrob Agents
; 28(5): 385-8, 2006 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17046205
14.
Ciprofloxacin DPI: a randomised, placebo-controlled, phase IIb efficacy and safety study on cystic fibrosis.
BMJ Open Respir Res
; 2(1): e000100, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26688732
15.
Clinical rationale for treatment of endocarditis caused by methicillin-susceptible Staphylococcus aureus developing nonsusceptibility to daptomycin.
J Clin Microbiol
; 46(7): 2471; author reply 2471-2, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18614667
16.
A comprehensive regulatory framework to address the unmet need for new antibacterial treatments.
Lancet Infect Dis
; 13(3): 269-75, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23332713
17.
The clinical relevance and correct designation of isolates nonsusceptible to daptomycin.
Clin Infect Dis
; 41(3): 411-2; author reply 412-3, 2005 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16007543
18.
Addressing the need for new antibacterials--authors' reply.
Lancet Infect Dis
; 13(10): 834-5, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24070560
19.
Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells.
Antimicrob Agents Chemother
; 51(12): 4255-60, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17923487
20.
Rapid bactericidal activity of daptomycin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus peritonitis in mice as measured with bioluminescent bacteria.
Antimicrob Agents Chemother
; 51(5): 1787-94, 2007 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-17307984